Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection

In addition to the severe impact of acute respiratory disease during the SARS-CoV-2 pandemic, the issue of “Long COVID” illness has impacted large numbers of patients following the initial infection. Wide ranges of Long Covid incidence have been reported, ranging from 30 to 87%. Long COVID has a var...

Descripción completa

Detalles Bibliográficos
Autores principales: Arostegui, Dalia, Castro, Kenny, Schwarz, Steven, Vaidy, Katherine, Rabinowitz, Simon, Wallach, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins, Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158423/
https://www.ncbi.nlm.nih.gov/pubmed/37168753
http://dx.doi.org/10.1097/PG9.0000000000000152
_version_ 1785036925752573952
author Arostegui, Dalia
Castro, Kenny
Schwarz, Steven
Vaidy, Katherine
Rabinowitz, Simon
Wallach, Thomas
author_facet Arostegui, Dalia
Castro, Kenny
Schwarz, Steven
Vaidy, Katherine
Rabinowitz, Simon
Wallach, Thomas
author_sort Arostegui, Dalia
collection PubMed
description In addition to the severe impact of acute respiratory disease during the SARS-CoV-2 pandemic, the issue of “Long COVID” illness has impacted large numbers of patients following the initial infection. Wide ranges of Long Covid incidence have been reported, ranging from 30 to 87%. Long COVID has a variety of clinical manifestations, including gastrointestinal symptoms. Here, we report a case of persistent abdominal pain, 3 months following a SARS-CoV-2 diagnosis, associated with chronic colonic inflammation and the presence of mucosal SARS-CoV-2 virions.
format Online
Article
Text
id pubmed-10158423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins, Inc.
record_format MEDLINE/PubMed
spelling pubmed-101584232023-05-09 Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection Arostegui, Dalia Castro, Kenny Schwarz, Steven Vaidy, Katherine Rabinowitz, Simon Wallach, Thomas JPGN Rep Case Report In addition to the severe impact of acute respiratory disease during the SARS-CoV-2 pandemic, the issue of “Long COVID” illness has impacted large numbers of patients following the initial infection. Wide ranges of Long Covid incidence have been reported, ranging from 30 to 87%. Long COVID has a variety of clinical manifestations, including gastrointestinal symptoms. Here, we report a case of persistent abdominal pain, 3 months following a SARS-CoV-2 diagnosis, associated with chronic colonic inflammation and the presence of mucosal SARS-CoV-2 virions. Lippincott Williams & Wilkins, Inc. 2021-12-03 /pmc/articles/PMC10158423/ /pubmed/37168753 http://dx.doi.org/10.1097/PG9.0000000000000152 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Arostegui, Dalia
Castro, Kenny
Schwarz, Steven
Vaidy, Katherine
Rabinowitz, Simon
Wallach, Thomas
Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title_full Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title_fullStr Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title_full_unstemmed Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title_short Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
title_sort persistent sars-cov-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158423/
https://www.ncbi.nlm.nih.gov/pubmed/37168753
http://dx.doi.org/10.1097/PG9.0000000000000152
work_keys_str_mv AT arosteguidalia persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection
AT castrokenny persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection
AT schwarzsteven persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection
AT vaidykatherine persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection
AT rabinowitzsimon persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection
AT wallachthomas persistentsarscov2nucleocapsidproteinpresenceintheintestinalepitheliumofapediatricpatient3monthsafteracuteinfection

Ejemplares similares